餐后脂肪酸结合蛋白4与肌肉胰岛素抵抗有关
Tsuyoshi Okura1, Yuichi Ito2, Mari Anno2
1Division of Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago, Tottori, Japan. ohkura@tottori-u.ac.jp.
Diabetologia
|July 26, 2024
概括
饭后脂肪酸结合蛋白4 (FABP4) 水平在2型糖尿病中升高,并与胰岛素抵抗有关. FABP4可能会抑制肌肉的胰岛素信号,影响葡萄糖的吸收.
科学领域:
- 代谢研究的研究.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 脂肪酸结合蛋白4 (FABP4) 与肝脏胰岛素抵抗有关.
- 之前的研究指出,禁食FABP4与胰岛素抵抗之间存在相关性,但在2型糖尿病 (T2D) 中食后FABP4及其肌肉作用尚不清楚.
研究的目的:
- 在T2D中调查食后FABP4水平.
- 阐明FABP4在肌肉胰岛素抵抗中的机制.
主要方法:
- 在T2D患者和对照组中进行了食耐受性测试和高胰岛素-高血糖.
- 测量禁食和食后血清的FABP4.
- 使用C2C12肌肉细胞进行体外研究,通过西布洛特和胰岛素结合测试来评估FABP4对葡萄糖吸收和胰岛素信号传递的影响.
主要成果:
- 与对照组相比,T2D患者的食后FABP4水平较高.
- 在T2D中,食后FABP4增加与胰岛素抵抗 (M/I值) 和葡萄糖变化相关.
- 单独使用FABP4可以增强肌肉细胞的葡萄糖吸收,但与胰岛素结合,它通过抑制胰岛素信号通路 (IRS-1,Akt酸化) 来减少吸收.
结论:
- 餐后FABP4升高与T2D中的胰岛素抵抗有关.
- FABP4似乎抑制了肌肉的胰岛素信号传递,从而导致胰岛素抵抗.
更多相关视频
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
11.7K
10:37Author Spotlight: Decellularization-Based Quantification of Skeletal Muscle Fatty Infiltration
Published on: June 9, 2023
3.0K
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
